Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Change in Account Payables (2017 - 2025)

Historic Change in Account Payables for Q32 Bio (QTTB) over the last 9 years, with Q3 2025 value amounting to $63000.0.

  • Q32 Bio's Change in Account Payables rose 10513.45% to $63000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$285000.0, marking a year-over-year increase of 7488.99%. This contributed to the annual value of -$1.0 million for FY2024, which is 15130.35% down from last year.
  • Q32 Bio's Change in Account Payables amounted to $63000.0 in Q3 2025, which was up 10513.45% from -$1.8 million recorded in Q2 2025.
  • Q32 Bio's Change in Account Payables' 5-year high stood at $7.7 million during Q1 2022, with a 5-year trough of -$6.1 million in Q2 2022.
  • Over the past 5 years, Q32 Bio's median Change in Account Payables value was -$100000.0 (recorded in 2021), while the average stood at -$236526.3.
  • Per our database at Business Quant, Q32 Bio's Change in Account Payables soared by 780100.0% in 2022 and then crashed by 285000.0% in 2024.
  • Over the past 5 years, Q32 Bio's Change in Account Payables (Quarter) stood at -$1.4 million in 2021, then tumbled by 170.67% to -$3.7 million in 2022, then surged by 144.39% to $1.6 million in 2023, then increased by 5.61% to $1.7 million in 2024, then plummeted by 96.36% to $63000.0 in 2025.
  • Its Change in Account Payables stands at $63000.0 for Q3 2025, versus -$1.8 million for Q2 2025 and -$277000.0 for Q1 2025.